1. Home
  2. ANNX vs GPRO Comparison

ANNX vs GPRO Comparison

Compare ANNX & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.53

Market Cap

334.1M

Sector

Health Care

ML Signal

HOLD

Logo GoPro Inc.

GPRO

GoPro Inc.

HOLD

Current Price

$1.83

Market Cap

282.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
GPRO
Founded
2011
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
334.1M
282.4M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
ANNX
GPRO
Price
$4.53
$1.83
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$16.60
N/A
AVG Volume (30 Days)
3.2M
3.7M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$650,751,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.29
$0.40
52 Week High
$5.66
$3.05

Technical Indicators

Market Signals
Indicator
ANNX
GPRO
Relative Strength Index (RSI) 65.87 56.34
Support Level $4.01 $1.57
Resistance Level $4.64 $1.68
Average True Range (ATR) 0.37 0.12
MACD 0.05 0.05
Stochastic Oscillator 76.03 91.49

Price Performance

Historical Comparison
ANNX
GPRO

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

Share on Social Networks: